Anti-CD79B antibodies and immunoconjugates and methods of use
US10494432B2 · kind B2 · utility
3Cited by
127References
118Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2013 |
| Grant date | Dec 3, 2019 |
| Priority date | — |
| Expiry date | Oct 3, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.